ACM
RNAM

ADAR1 Capital Management’s Avidity Biosciences RNAM Stock Holding History

ADAR1 Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-546,534
Closed -$39.4M – 337
2025
Q4 		$39.4M Buy
546,534
+492,878
+919% +$31.8M 2.9% 5
2025
Q3 		$2.34M Buy
+53,656
New +$2.17M 0.22% 72
2024
Q4 		– Sell
-600
Closed -$27.6K – 289
2024
Q3 		$27.6K Buy
+600
New +$26K ﹤0.01% 237

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

ADAR1 Capital Management's RNAM Position: Q1 2026 in Review

ADAR1 Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 546,534 shares — an estimated $39.4M sold.

ADAR1 Capital Management first reported a position in RNAM in Q3 2024 and held it in 3 quarters. The position peaked at $39.4M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • ADAR1 Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 546,534 Avidity Biosciences shares in Q1 2026, an estimated $39.4M.
  • ADAR1 Capital Management first reported a position in Avidity Biosciences in Q3 2024 and held it in 3 quarters.
  • ADAR1 Capital Management's Avidity Biosciences position peaked at $39.4M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.